Clinical Trials Directory

Trials / Completed

CompletedNCT03034057

Sayana Press UK Self-Injection Study

PHASE IV OPEN LABEL SINGLE GROUP ONE YEAR STUDY OF HOME SELF-INJECTION WITH SAYANA (REGISTERED) PRESS IN ADULT WOMEN OF REPRODUCTIVE AGE - A PRAGMATIC CLINICAL TRIAL

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
169 (actual)
Sponsor
Pfizer · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

A one-year evaluation of Sayana Press self injection in women of reproductive age in the United Kingdom (UK).

Conditions

Interventions

TypeNameDescription
DRUGSayana PressSayana Press in the Uniject injection system

Timeline

Start date
2017-08-23
Primary completion
2018-12-07
Completion
2018-12-07
First posted
2017-01-27
Last updated
2019-10-18
Results posted
2019-10-18

Locations

28 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03034057. Inclusion in this directory is not an endorsement.